Four years since the covid pandemic emerged, health care workers want rules that protect them during outbreaks. They worry the CDC is repeating past mistakes as it develops a crucial set of guidelines for hospitals, nursing homes, prisons, and other facilities that provide health care.
Demand for help monitoring patients’ vital signs remotely has taken off since a Medicare change in 2019. Dozens of companies now push the service to help overburdened primary care doctors — and as a revenue stream. But some policy experts say its growth has outpaced oversight and evidence of effectiveness.
Demand for help monitoring patients’ vital signs remotely has taken off since a Medicare change in 2019. Dozens of companies now push the service to help overburdened primary care doctors — and as a revenue stream. But some policy experts say its growth has outpaced oversight and evidence of effectiveness.
Price worries, bureaucratic obstacles, and “I’m-over-covid-itis” slow uptake of a drug that’s complicated to take but often effective.
At last, Congress is getting half of its annual spending bills across the finish line, albeit five months after the start of the fiscal year. Meanwhile, President Joe Biden delivers his annual State of the Union address, an over-the-counter birth control pill is (finally) available, and controversy erupts over new public health guidelines for covid-19 isolation. Alice Miranda Ollstein of Politico, Sarah Karlin-Smith of the Pink Sheet, and Sandhya Raman of CQ Roll Call join KFF Health News’ Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Neera Tanden, the White House domestic policy adviser, about Biden’s health agenda. Plus, for “extra credit,” the panelists suggest health policy stories they read this week that they think you should read, too.
A federal district court judge dismissed a lawsuit attempting to invalidate the Biden administration’s Medicare prescription-drug price negotiation program. But the suit turned on a technicality, and several more court challenges are in the pipeline. Meanwhile, health policy pops up in Super Bowl ads, as Congress approaches yet another funding deadline. Alice Miranda Ollstein of Politico, Lauren Weber of The Washington Post, and Rachel Cohrs of Stat join KFF Health News’ Julie Rovner to discuss these issues and more. Plus, for “extra credit,” the panelists suggest health policy stories they read this week they think you should read, too.
KFF Health News’ Céline Gounder explains the “five-day rule” on covid safety, how guidelines and testing have evolved, and how best to protect yourself and others.
Recently, thousands of older Americans have been dying weekly of covid. But most Americans aren’t wearing masks in public, a move that could prevent infections. Many at-risk seniors aren’t getting antiviral therapies, and older adults in nursing homes aren’t getting vaccines. Why?
Facts don’t support claims by a likely Republican Senate candidate that a federal research laboratory in Montana infected bats with a coronavirus from China before the covid-19 outbreak.
Opposition to vaccines and other public health measures backed by science has become politically charged. That makes dangerous misinformation much harder to fight.
